IRIS Accounts Production v25.2.0.378 SC490538 Board of Directors 31.12.23 30.12.24 30.12.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC4905382023-12-30SC4905382024-12-30SC4905382023-12-312024-12-30SC4905382022-12-30SC4905382022-12-312023-12-30SC4905382023-12-30SC490538ns15:Scotland2023-12-312024-12-30SC490538ns14:PoundSterling2023-12-312024-12-30SC490538ns10:Director12023-12-312024-12-30SC490538ns10:PrivateLimitedCompanyLtd2023-12-312024-12-30SC490538ns10:SmallEntities2023-12-312024-12-30SC490538ns10:AuditExempt-NoAccountantsReport2023-12-312024-12-30SC490538ns10:SmallCompaniesRegimeForDirectorsReport2023-12-312024-12-30SC490538ns10:SmallCompaniesRegimeForAccounts2023-12-312024-12-30SC490538ns10:FullAccounts2023-12-312024-12-30SC490538ns10:Director22023-12-312024-12-30SC490538ns10:CompanySecretary12023-12-312024-12-30SC490538ns10:RegisteredOffice2023-12-312024-12-30SC490538ns5:CurrentFinancialInstruments2024-12-30SC490538ns5:CurrentFinancialInstruments2023-12-30SC490538ns5:Non-currentFinancialInstruments2024-12-30SC490538ns5:Non-currentFinancialInstruments2023-12-30SC490538ns5:ShareCapital2024-12-30SC490538ns5:ShareCapital2023-12-30SC490538ns5:RetainedEarningsAccumulatedLosses2024-12-30SC490538ns5:RetainedEarningsAccumulatedLosses2023-12-30SC490538ns5:PlantMachinery2023-12-312024-12-30SC490538ns5:ComputerEquipment2023-12-312024-12-30SC490538ns5:PlantMachinery2023-12-30SC490538ns5:ComputerEquipment2023-12-30SC490538ns5:PlantMachinery2024-12-30SC490538ns5:ComputerEquipment2024-12-30SC490538ns5:PlantMachinery2023-12-30SC490538ns5:ComputerEquipment2023-12-30SC490538ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-30SC490538ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-30
REGISTERED NUMBER: SC490538 (Scotland)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 DECEMBER 2024

FOR

DOCTOR Q LIMITED

DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


DOCTOR Q LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 DECEMBER 2024







DIRECTORS: Dr U Qureshi
Mrs S M Qureshi





SECRETARY: Mrs S M Qureshi





REGISTERED OFFICE: 31 Thorn Road
Bearsden
Glasgow
G61 4BS





REGISTERED NUMBER: SC490538 (Scotland)





ACCOUNTANTS: JF Accounting
Clyde Offices, 2nd Floor,
48 West George Street
Glasgow
G2 1BP

DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538)

BALANCE SHEET
30 DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 369 435

CURRENT ASSETS
Debtors 5 1,758,497 1,732,826
Cash at bank 71 155
1,758,568 1,732,981
CREDITORS
Amounts falling due within one year 6 1,006,742 923,896
NET CURRENT ASSETS 751,826 809,085
TOTAL ASSETS LESS CURRENT
LIABILITIES

752,195

809,520

CREDITORS
Amounts falling due after more than
one year

7

32,011

36,498
NET ASSETS 720,184 773,022

CAPITAL AND RESERVES
Called up share capital 10 10
Retained earnings 720,174 773,012
720,184 773,022

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538)

BALANCE SHEET - continued
30 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 September 2025 and were signed on its behalf by:





Dr U Qureshi - Director


DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 DECEMBER 2024

1. STATUTORY INFORMATION

Doctor Q Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
The directors have considered the going concern basis in preparing these financial statements. They have concluded that the going concern basis is appropriate because sufficient funds will be generated from future trading of the company, as well as continued support from the directors and group companies, for a period of at least twelve months from the date of the approval of these financial statements to enable the Company to meet its liabilities as they arise.

The financial statements do not include any adjustments that would result from the withdrawal of this support.

The company has claimed the covid bounce back loans in more than one group company. As a result, this has been shown as fully due in 1 year.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on cost
Computer equipment - 15% on reducing balance

Financial instruments
The company only enters into basic financial instruments that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of Income and Retained Earnings.


DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 DECEMBER 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 31 December 2023
and 30 December 2024 17,330 1,424 18,754
DEPRECIATION
At 31 December 2023 17,330 989 18,319
Charge for year - 66 66
At 30 December 2024 17,330 1,055 18,385
NET BOOK VALUE
At 30 December 2024 - 369 369
At 30 December 2023 - 435 435

DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 DECEMBER 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 9,045 2,670
Amounts owed by group undertakings 1,443,585 1,424,289
Amounts owed by associates 303,437 303,437
Prepayments 2,430 2,430
1,758,497 1,732,826

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other loans 7,538 89,157
Trade creditors - 16,967
Amounts owed to group undertakings 970,731 795,681
Amounts owed to participating interests 1,500 1,500
Tax 2,825 2,825
VAT 5,513 12,246
Other creditors - 61
Accrued expenses 18,635 5,459
1,006,742 923,896

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Other loans - 1-2 years 5,871 7,538
Other loans - 2-5 years 26,140 28,960
32,011 36,498

8. RELATED PARTY DISCLOSURES

During the period the Company operated loan accounts with group companies which is included within debtors. The amount due from group companies at the period end was £472,855 ( 2023 - £628,608). These loans are unsecured, interest free and repayable on demand.

During the period the Company operated a loan account with companies under common control. The amount due from companies under common control was £303,437 (2023 - £303,437). This loan is unsecured, interest and repayable on demand.

During the period the Company owed interested parties by virtue of their 100% shareholding in Qureshi Group Limited £1,500 (2023 - £1,500)

DOCTOR Q LIMITED (REGISTERED NUMBER: SC490538)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 DECEMBER 2024

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling parent undertaking is Qureshi Group Limited by virtue of its 100% controlling interest in the company.

The Ultimate controlling parties are Dr U Qureshi and Mrs S Qureshi by virtue of their 100% shareholding in Qureshi Group Limited.